Shanghai, China

Yunfei Li

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Suzhou, CN (2018)
  • Shanghai, CN (2019 - 2023)

Company Filing History:


Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

8 patents (USPTO):

Title: Innovator Spotlight on Yunfei Li: Pioneering JAK Inhibitors in Medicinal Chemistry

Introduction

Yunfei Li, based in Shanghai, China, is a prominent inventor in the field of medicinal chemistry with a remarkable portfolio of six patents. His innovative work focuses primarily on JAK kinase inhibitors, significantly contributing to advancements in medical treatments. This article explores his latest patents, career highlights, and collaborations that showcase his impact on the pharmaceutical industry.

Latest Patents

Yunfei Li has made significant strides with his recent patents, notably in the development of a novel small molecule JAK inhibitor. This compound features the structure represented by formula (II) and provides enhanced efficacy and safety for preventing or treating JAK-related conditions. His work extends into the preparation of a powder injection of donepezil semi palmoxiric acid salt, which includes a composition containing donepezil in a form that crystallizes with an average particle size of 2-52 micrometers. These advancements reflect his commitment to improving therapeutic options in medicine.

Career Highlights

Li has worked with several esteemed organizations, notably Shanghai Synergy Pharmaceutical Sciences Co., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. His expertise in medicinal chemistry and innovative solutions has positioned him as a leading figure in pharmaceutical invention, pushing the boundaries of treatment capabilities.

Collaborations

Throughout his career, Yunfei Li has collaborated with talented professionals such as Jian Ge and Yijin Wang, contributing to joint efforts in advancing pharmaceutical research and development. These partnerships have enhanced the output of innovative solutions in the medical field, further solidifying Li's position as a key inventor.

Conclusion

Yunfei Li's contributions to the field of medicinal chemistry through his patents on JAK inhibitors and related compositions hold promise for improving patient outcomes in various medical conditions. His work not only reflects innovative thinking but also exemplifies the impact of collaboration in driving pharmaceutical advancements. Yunfei Li continues to inspire future inventors in the world of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…